SCHEMBL13701347

SCHEMBL13701347

COc1ccc(C(c2ccc(C=O)cc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.76
CYP2A6 P11509 1/20 0.76
SLC2A1 P11166 1/20 0.53
TYR P14679 1/20 0.52
ALDH1A3 P47895 1/20 0.52
GSK3B P49841 1/20 0.46
TSHR P16473 2/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.45
KDM4E B2RXH2 1/20 0.45
F3 P13726 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
TRPA1 O75762 1/20 0.44
RELA Q04206 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anisaldehyde SCHEMBL717471 0.87 ALDH1A1 (1.00) ALDH1A1CYP2A6ALDH1A3GSK3BTSHR
Anisaldehyde SCHEMBL1100 0.87 ALDH1A1 (1.00) ALDH1A1CYP2A6ALDH1A3GSK3BTSHR
SCHEMBL5604880 0.86 ALDH1A1 (0.73) ALDH1A1CYP2A6TYRALDH1A3TSHR
Anisaldehyde SCHEMBL31123393 0.85 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3GSK3BTSHR
Anisaldehyde SCHEMBL11255570 0.85 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3GSK3BTSHR
Anisaldehyde SCHEMBL1475478 0.85 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3GSK3BTSHR
Anisaldehyde SCHEMBL28556480 0.85 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3GSK3BTSHR
Anisaldehyde SCHEMBL1477047 0.85 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3GSK3BTSHR
Anisaldehyde SCHEMBL28973891 0.85 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3GSK3BTSHR
Anisaldehyde SCHEMBL28776745 0.85 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3GSK3BTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318699-B2 Tumor necrosis factor inhibitors THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2012-11-27 US disclosed
US-20090221527-A1 TUMOR NECROSIS FACTOR INHIBITORS CEPTION THERAPEUTICS, INC. (US) 2009-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221527-A1 TUMOR NECROSIS FACTOR INHIBITORS TNFRSF1A, TNF, TNFRSF9 ALDH1A1 3912/4885CYP2A6 4354/4885SLC2A1 4628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.